Evaluation of Renal Impairment in Patients with Diabetic Kidney Disease by Integrated Chinese and Western Medicine

Yi-Lun QU; Zhe-Yi DONG; Hai-Mei CHENG; Qian LIU; Qian WANG; Hong-Tao YANG; Yong-Hui MAO; Ji-Jun LI; Hong-Fang LIU; Yan-Qiu GENG; Wen HUANG; Wen-Hu LIU; Hui-di XIE; Fei PENG; Shuang LI; Shuang-Shuang JIANG; Wei-Zhen LI; Shu-Wei DUAN; Zhe FENG; Wei-Guang ZHANG; Yu-Ning LIU; Jin-Zhou TIAN; Xiang-Mei CHEN.
Chinese journal of integrative medicine ; (12): 308-315, 2023.
Artículo en Inglés | WPRIM | ID: wpr-982278

Documentos relacionados

  1. Evaluation of Renal Impairment in Patients with Diabetic Kidney Disease by Integrated Chinese and Western Medicine.
  2. Study on the relationship between lipoprotein (a) and diabetic kidney disease.
  3. Association Between Serum Homocysteine Levels and Severity of Diabetic Kidney Disease in 489 Patients with Type 2 Diabetes Mellitus: A Single-Center Study.
  4. Urinary Post-Translationally Modified Fetuin-A (uPTM-FetA) in Chronic Kidney Disease Patients with and without Diabetic Kidney Disease.
  5. Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease.
  6. SGLT2 inhibition requires reconsideration of fundamental paradigms in chronic kidney disease, 'diabetic nephropathy', IgA nephropathy and podocytopathies with FSGS lesions.
  7. Finerenone.
  8. Association of Serum Zinc Level with severity of chronic kidney disease in diabetic patients: a cross-sectional study.
  9. Therapeutic perspective: evolving evidence of nonsteroidal mineralocorticoid receptor antagonists in diabetic kidney disease.
  10. Methionine and total homocysteine in hypertensive patients with renal excretory dysfunction.